Non-peptide

4′-DMA-7,8-DHF

Also known as

4-DMA-7,8-DHF · 4DMA · 4-DMA · Eutropoflavin · 4′-dimethylamino-7,8-dihydroxyflavone · 4'-DMA-7,8-DHF · 7,8-DHF analog · TrkB agonist flavone

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Identity	A synthetic flavone also called Eutropoflavin, discussed for mood and focus.
Forms discussed	Swallowed capsules or powder held under the tongue. Plain 7,8-DHF is a different compound with different amounts.

Notes

4′-DMA-7,8-DHF, also called Eutropoflavin or 4DMA, is a synthetic flavone discussed for mood, focus and easier engagement with work or people. Accounts range from useful energy to no effect, fog or prolonged sleep disruption. Its human benefits and safety are not established by these reports.

A modified flavone, not a peptide. Eutropoflavin is the short name for 4′-dimethylamino-7,8-dihydroxyflavone, a synthetic relative of 7,8-DHF. Community use involves swallowed capsules or powder held under the tongue, rather than peptide injections.

The parent compound is a separate identity. The 2021 dose discussion compared an 8 mg 4DMA capsule with 25 mg plain 7,8-DHF. Those milligrams are not interchangeable; stronger marketing does not establish which compound suits a person. 4′-DMA-7,8-DHF dose inquiry (Secondhand community claim · Accessed 2026-09-30)

Source context — 4′-DMA-7,8-DHF dose inquiry: Commercially interested vendor participation in a public forum. Internal testing is not a clinical dose-ranging study or a safety ceiling; no sourcing instructions carried forward.

What people notice

Attention and recall	Some report easier task starts, smoother focus, better recall and verbal fluency. Others notice nothing or feel sleepier.
Mood and social ease	One oral user described better mood, confidence and eye contact over two weeks, with greater flexibility under stress in a later update.
Mixed sleep changes	Reports include longer sleep and vivid dreams, but also severe insomnia and next-day exhaustion.

Notes

More workable attention. One recent commenter described less resistance to starting tasks and smoother movement between them. BowTiedNeuron called it an unusually strong personal cognitive enhancer; that creator supplied no route or amount. Eutropoflavin / 4 DMA-7,8 DHF – experiences? (Personal report · Accessed 2026-09-30) · BowTiedNeuron Monthly Q&A #2 public comments (Personal report · Accessed 2026-09-30)

Recall and verbal fluency. A work-and-exam user described better recall, conversation and energy alongside other compounds, then feeling unusually slow off-use. Other reports add coding flow, less rumination and stamina; others describe sleepiness or no improvement. 4′-DMA-7,8-DHF: strong work effects and a difficult off-period (Community discussion · Accessed 2026-09-30)

A second attempt changed one person's outcome. The swallowed-capsule author first had severe insomnia, then months later reported mood/energy benefit without that problem, with coffee alongside it. Another contributor felt nothing orally or under the tongue. My experience with 4′-DMA-7,8-DHF (Community discussion · Accessed 2026-09-30)

Mood and social ease. An oral user reported improved mood, greater confidence and easier eye contact over two weeks. Their later two-month update described better flexibility under stress. This is one evolving account, not a depression-treatment trial. My experience so far with 4′-DMA-7,8-DHF (Personal report · Accessed 2026-09-30)

More sleep can coexist with afternoon insomnia. The 8 mg oral diarist's early fatigue/fog faded, with longer sleep and enjoyable dreams; they also reported difficulty sleeping after afternoon use. Caffeine, theanine and other supplements accompanied the experience, and learning effects were initially unclear. My experience so far with 4′-DMA-7,8-DHF (Personal report · Accessed 2026-09-30)

Long-feel ranges hide the sleep tradeoff. Reported 8–20-hour and 12–20-hour descriptions remain subjective ranges. Some favorable daytime effects are followed by insomnia and next-day exhaustion; some users notice no effect at all. 4dma 7,8 peaks in about 4 hours (Community discussion · Accessed 2026-09-30) · My experience with 4′-DMA-7,8-DHF (Community discussion · Accessed 2026-09-30)

Source context — Eutropoflavin / 4 DMA-7,8 DHF – experiences?: Anonymous, uncontrolled self-reports; product identity and amounts not independently verified. Co-use, expectations and selective posting prevent causal or prevalence claims. Only public visible bodies/replies inspected. OP interprets symptoms as neuroregeneration; that interpretation is not adopted. Search excerpt included later updates absent from opened body; those updates are not credited as fresh inspected evidence.

Source context — BowTiedNeuron Monthly Q&A #2 public comments: Public comment bodies inspected; main newsletter is paid. Creator opinion with commercial subscription context, no amount or route supplied; direct-TrkB mechanism asserted without primary evidence here.

Source context — 4′-DMA-7,8-DHF: strong work effects and a difficult off-period / My experience with 4′-DMA-7,8-DHF / My experience so far with 4′-DMA-7,8-DHF / 4dma 7,8 peaks in about 4 hours: Anonymous, uncontrolled self-reports; product identity and amounts not independently verified. Co-use, expectations and selective posting prevent causal or prevalence claims. Only public visible bodies/replies inspected.

Doses people talk about

Oral reports	8–10 mg in the morning; separate diaries describe 8 mg once daily and 10 mg orally daily.
Other reported amounts	20 mg appears after fading effects or as a one-off sublingual experiment. One mixed stack felt worse at 15–20 mg sublingually; 4–6 mg the next day brought no reported adverse effects.
Higher sublingual report	One commenter described 30 mg, or three capsules, held under the tongue for mood dips. This is a separate report, not a usual daily total.

Notes

Oral: 8–10 mg in morning accounts. One diary specifies 8 mg once daily, most mornings for two weeks; a separate project report specifies 10 mg orally daily. These are reported amounts, not a dose recommendation. My experience so far with 4′-DMA-7,8-DHF (Personal report · Accessed 2026-09-30) · 4′-DMA-7,8-DHF: strong work effects and a difficult off-period (Community discussion · Accessed 2026-09-30)

20 mg and smaller sublingual experiments. Community notes retain 20 mg after fading effects or as a one-off sublingual experiment. One account used approximately 15–20 mg under the tongue with other compounds and felt worse; 4–6 mg the next day brought no reported adverse effects. Eutropoflavin / 4 DMA-7,8 DHF – experiences? (Personal report · Accessed 2026-09-30)

30 mg is a separate high-amount report. A commenter describes 30 mg, identified as three capsules, held under the tongue for mood dips. Capsule contents were not verified. This does not establish a normal daily total or a progression to follow. My experience with 4′-DMA-7,8-DHF (Community discussion · Accessed 2026-09-30)

Source context — My experience so far with 4′-DMA-7,8-DHF / 4′-DMA-7,8-DHF: strong work effects and a difficult off-period / My experience with 4′-DMA-7,8-DHF: Anonymous, uncontrolled self-reports; product identity and amounts not independently verified. Co-use, expectations and selective posting prevent causal or prevalence claims. Only public visible bodies/replies inspected.

Half-life, onset & duration

Felt onset	Some describe 30–90 minutes; one sublingual user felt a subtle immediate change that grew around four hours. Another noticed nothing until over three hours.
Felt duration	Accounts range from a crash at six hours to roughly 36 hours of stimulation. Older 8–20-hour and 12–20-hour descriptions are subjective reports.
Half-life	A measured human 4DMA half-life is not established here. Parent-compound estimates and AI-generated numbers do not supply one.

Notes

Immediate, delayed and absent responses occur. A sublingual user felt a subtle shift immediately, with stronger mood/focus around four hours. Another noticed nothing until three-plus hours, whether swallowed or sublingual. 4dma 7,8 peaks in about 4 hours (Community discussion · Accessed 2026-09-30) · 4′-DMA-7,8-DHF and sleep (less) effects (Community discussion · Accessed 2026-09-30)

The older 30–90-minute account remains a report. Community notes describe this early mood/energy window, particularly under the tongue, and slower oral-with-food onset. Repeated-day mood changes and early fog are separate timelines; food or route does not guarantee speed.

Six hours and 36 hours describe different people. One commenter crashes at hour six; another describes background stimulation into the next day, about 36 hours. Neither establishes a typical duration or measured clearance. 4dma 7,8 peaks in about 4 hours (Community discussion · Accessed 2026-09-30) · My experience with 4′-DMA-7,8-DHF (Community discussion · Accessed 2026-09-30)

A measured human 4DMA half-life remains unknown. One reply gives 12–16 hours, possibly 24, explicitly from Gemini and ChatGPT. The writer's longer stimulation cannot validate those AI-generated numbers. My experience with 4′-DMA-7,8-DHF (Community discussion · Accessed 2026-09-30)

Parent-scaffold lore is different. Community discussion quotes about 2–2.5 hours for the parent scaffold, without establishing its measurement source. That is not a demonstrated human 4DMA elimination time, and an 8–20-hour feeling is not bodily half-life.

Source context — 4dma 7,8 peaks in about 4 hours / 4′-DMA-7,8-DHF and sleep (less) effects / My experience with 4′-DMA-7,8-DHF: Anonymous, uncontrolled self-reports; product identity and amounts not independently verified. Co-use, expectations and selective posting prevent causal or prevalence claims. Only public visible bodies/replies inspected.

Cycles people discuss

Reported calendars	One user described two weeks on and 4–12 weeks off; others describe daily use for two months or occasional use around once monthly.
Other patterns	One day on/one off, one on/two off and a few uses yearly also appear. The 4–12 weeks on chart is promotional guidance, not the two-week user's calendar.
Fading effects	People discuss breaks for fading benefits or sleep problems. One long-term user did not regain benefit with Polygala or four-to-five-month breaks.

Notes

Actual calendars differ. One user reports two weeks on, four to twelve weeks off. The Biomogging guide instead circulates four to twelve weeks on; that is a promotional chart, not the same person's diary or an established course. 4′-DMA-7,8-DHF: strong work effects and a difficult off-period (Community discussion · Accessed 2026-09-30) · Biomogging Eutropoflavin dose/cycle guide (Community guide · Accessed 2026-09-30)

Daily and occasional use both appear. The two-month diary describes daily use. Another contributor uses it roughly monthly; BowTiedNeuron uses it when wanting acute enhancement. Amounts and routes are missing in the occasional-use accounts. My experience so far with 4′-DMA-7,8-DHF (Personal report · Accessed 2026-09-30) · 4dma 7,8 peaks in about 4 hours (Community discussion · Accessed 2026-09-30) · BowTiedNeuron Monthly Q&A #2 public comments (Personal report · Accessed 2026-09-30)

Other on/off experiments remain in the discussion. Community notes include one day on/one off, one on/two off, daily use for months and a few uses per year. Breaks are discussed around fading effects and sleep costs; no calendar demonstrates prevention of receptor changes or long-term harm.

Breaks and Polygala do not settle tolerance. Community notes describe 8→20 mg escalation over weeks and Polygala as a proposed workaround. A long-term commenter lost benefit after about 18 months despite intermittent use; Polygala and later four-to-five-month breaks did not restore it. Receptor downregulation remains an explanation people propose. 4′-DMA-7,8-DHF: strong work effects and a difficult off-period (Community discussion · Accessed 2026-09-30)

Source context — 4′-DMA-7,8-DHF: strong work effects and a difficult off-period / My experience so far with 4′-DMA-7,8-DHF / 4dma 7,8 peaks in about 4 hours: Anonymous, uncontrolled self-reports; product identity and amounts not independently verified. Co-use, expectations and selective posting prevent causal or prevalence claims. Only public visible bodies/replies inspected.

Source context — Biomogging Eutropoflavin dose/cycle guide: Promotional performance/stack guide; not a first-person diary or independently verified consensus. Misstates older capsule origin as10mg against contemporary8mg vendor discussion. Rodent findings generalized to human regimen; unsupported continuous-use/no-withdrawal/no-organ-effect assurances rejected.

Stacks

Caffeine and theanine	A morning combination appears in reports, including the oral mood diary.
Polygala	Discussed as a tolerance workaround; the saved accounts do not show that it reliably restores fading effects.
Other combinations	Phenylpiracetam, Semax and Dihexa appear in stack discussions. Taking several compounds makes each one's contribution unclear.

Notes

Caffeine and theanine: Appear in morning accounts and complicate attribution of attention, energy and sleep effects. [community]

Polygala: A proposed tolerance workaround; one longer-term account reported that it did not restore lost benefit. [community]

Stacks complicate the focus story. Caffeine with theanine, phenylpiracetam, Semax and Dihexa appear in community discussions; pairing use with learning sessions also appears. These accounts cannot identify each ingredient's contribution or prove stack synergy.

Phenylpiracetam: Appears in multi-compound use. Concurrent stimulation makes benefit and sleep effects harder to attribute and does not establish safe combination use. [community]

Semax and Dihexa: Appear together in cognitive-enhancement discussions. Shared signaling language does not establish synergy or identify each ingredient's contribution. [community]

Source context — My experience so far with 4′-DMA-7,8-DHF / 4′-DMA-7,8-DHF: strong work effects and a difficult off-period: Anonymous, uncontrolled self-reports; product identity and amounts not independently verified. Co-use, expectations and selective posting prevent causal or prevalence claims. Only public visible bodies/replies inspected.

Watch for

Insomnia	Some could not sleep even after 6–7 a.m. use; morning dosing does not guarantee normal sleep.
Unpleasant effects	Headache, anxiety, fog, irritability and feeling depressed while stimulated are reported. Several accounts also involved other compounds.
Human safety	Long-term safety and interactions remain unresolved. Mouse findings do not establish human brain repair or safe continuous use.

Notes

Early use does not guarantee sleep. Accounts describe delayed sleep even after 6–7 a.m. use. One user instead slept longer. A morning-only rule is a personal precaution, not a reliable solution. 4′-DMA-7,8-DHF and sleep (less) effects (Community discussion · Accessed 2026-09-30) · My experience so far with 4′-DMA-7,8-DHF (Personal report · Accessed 2026-09-30)

Stimulation can feel unpleasant. Reports include headaches, anxiety, fog, irritability and feeling depressed while stimulated. Several recent symptoms occurred with other compounds, so assigning all of them to 4DMA would overstate the account. Eutropoflavin / 4 DMA-7,8 DHF – experiences? (Personal report · Accessed 2026-09-30) · 4′-DMA-7,8-DHF: strong work effects and a difficult off-period (Community discussion · Accessed 2026-09-30) · 4dma 7,8 peaks in about 4 hours (Community discussion · Accessed 2026-09-30)

Human safety and combinations remain unresolved. Community notes retain unknown long-term safety. Pregnancy/breastfeeding and overlapping investigational compounds are cautions raised in the guide, without human safety or interaction evidence. No reassuring lack-of-withdrawal or continuous-use promise follows. Biomogging Eutropoflavin dose/cycle guide (Community guide · Accessed 2026-09-30)

Why BDNF and TrkB appear in the discussion. BDNF is a signaling protein; TrkB is its receptor. Mouse findings motivated interest in 4DMA, without establishing human brain repair or permanent cognitive enhancement. Jiang et al.: TrkB compounds in Huntington-model mice (Animal context · Accessed 2026-09-30) · Eutropoflavin / 4 DMA-7,8 DHF – experiences? (Personal report · Accessed 2026-09-30)

Source context — 4′-DMA-7,8-DHF and sleep (less) effects / My experience so far with 4′-DMA-7,8-DHF / 4′-DMA-7,8-DHF: strong work effects and a difficult off-period / 4dma 7,8 peaks in about 4 hours: Anonymous, uncontrolled self-reports; product identity and amounts not independently verified. Co-use, expectations and selective posting prevent causal or prevalence claims. Only public visible bodies/replies inspected.

Source context — Jiang et al.: TrkB compounds in Huntington-model mice: PubMed abstract and figure legends inspected, not full paper. Mouse disease model provides no human dose, elimination half-life, clinical depression efficacy or long-term safety.

Full notes

What 4DMA is

A modified flavone, not a peptide. Eutropoflavin is the short name for 4′-dimethylamino-7,8-dihydroxyflavone, a synthetic relative of 7,8-DHF. Community use involves swallowed capsules or powder held under the tongue, rather than peptide injections. Community
Why BDNF and TrkB appear in the discussion. BDNF is a signaling protein; TrkB is its receptor. Mouse findings motivated interest in 4DMA, without establishing human brain repair or permanent cognitive enhancement. Animal context Personal report
The parent compound is a separate identity. The 2021 dose discussion compared an 8 mg 4DMA capsule with 25 mg plain 7,8-DHF. Those milligrams are not interchangeable; stronger marketing does not establish which compound suits a person. Reddit Community

What people hope to feel

More workable attention. One recent commenter described less resistance to starting tasks and smoother movement between them. BowTiedNeuron called it an unusually strong personal cognitive enhancer; that creator supplied no route or amount. Personal report Personal report
Mood and social ease. An oral user reported improved mood, greater confidence and easier eye contact over two weeks. Their later two-month update described better flexibility under stress. This is one evolving account, not a depression-treatment trial. Personal report
Recall and verbal fluency. A work-and-exam user described better recall, conversation and energy alongside other compounds, then feeling unusually slow off-use. Other reports add coding flow, less rumination and stamina; others describe sleepiness or no improvement. Reddit Community

Doses people discuss

Oral: 8–10 mg in morning accounts. One diary specifies 8 mg once daily, most mornings for two weeks; a separate project report specifies 10 mg orally daily. These are reported amounts, not a dose recommendation. Personal report Reddit
20 mg and smaller sublingual experiments. Community notes retain 20 mg after fading effects or as a one-off sublingual experiment. One account used approximately 15–20 mg under the tongue with other compounds and felt worse; 4–6 mg the next day brought no reported adverse effects. Community Personal report
30 mg is a separate high-amount report. A commenter describes 30 mg, identified as three capsules, held under the tongue for mood dips. Capsule contents were not verified. This does not establish a normal daily total or a progression to follow. Reddit

Half-life: what the numbers actually mean

A measured human 4DMA half-life remains unknown. One reply gives 12–16 hours, possibly 24, explicitly from Gemini and ChatGPT. The writer's longer stimulation cannot validate those AI-generated numbers. Reddit
Parent-scaffold lore is different. Community discussion quotes about 2–2.5 hours for the parent scaffold, without establishing its measurement source. That is not a demonstrated human 4DMA elimination time, and an 8–20-hour feeling is not bodily half-life. Community

When people first notice something

Immediate, delayed and absent responses occur. A sublingual user felt a subtle shift immediately, with stronger mood/focus around four hours. Another noticed nothing until three-plus hours, whether swallowed or sublingual. Reddit Reddit
The older 30–90-minute account remains a report. Community notes describe this early mood/energy window, particularly under the tongue, and slower oral-with-food onset. Repeated-day mood changes and early fog are separate timelines; food or route does not guarantee speed. Community

How long the feeling lasts

Six hours and 36 hours describe different people. One commenter crashes at hour six; another describes background stimulation into the next day, about 36 hours. Neither establishes a typical duration or measured clearance. Reddit Reddit
Long-feel ranges hide the sleep tradeoff. Reported 8–20-hour and 12–20-hour descriptions remain subjective ranges. Some favorable daytime effects are followed by insomnia and next-day exhaustion; some users notice no effect at all. Community Reddit Reddit

Repeated use and breaks

Actual calendars differ. One user reports two weeks on, four to twelve weeks off. The Biomogging guide instead circulates four to twelve weeks on; that is a promotional chart, not the same person's diary or an established course. Reddit Community guide
Daily and occasional use both appear. The two-month diary describes daily use. Another contributor uses it roughly monthly; BowTiedNeuron uses it when wanting acute enhancement. Amounts and routes are missing in the occasional-use accounts. Personal report Reddit Personal report
Other on/off experiments remain in the discussion. Community notes include one day on/one off, one on/two off, daily use for months and a few uses per year. Breaks are discussed around fading effects and sleep costs; no calendar demonstrates prevention of receptor changes or long-term harm. Community Community

Good to know before interpreting the reports

Early use does not guarantee sleep. Accounts describe delayed sleep even after 6–7 a.m. use. One user instead slept longer. A morning-only rule is a personal precaution, not a reliable solution. Reddit Personal report
Stimulation can feel unpleasant. Reports include headaches, anxiety, fog, irritability and feeling depressed while stimulated. Several recent symptoms occurred with other compounds, so assigning all of them to 4DMA would overstate the account. Personal report Reddit Reddit
Human safety and combinations remain unresolved. Community notes retain unknown long-term safety. Pregnancy/breastfeeding and overlapping investigational compounds are cautions raised in the guide, without human safety or interaction evidence. No reassuring lack-of-withdrawal or continuous-use promise follows. Community Community guide

What the experiences add

More sleep can coexist with afternoon insomnia. The 8 mg oral diarist's early fatigue/fog faded, with longer sleep and enjoyable dreams; they also reported difficulty sleeping after afternoon use. Caffeine, theanine and other supplements accompanied the experience, and learning effects were initially unclear. Personal report
A second attempt changed one person's outcome. The swallowed-capsule author first had severe insomnia, then months later reported mood/energy benefit without that problem, with coffee alongside it. Another contributor felt nothing orally or under the tongue. Reddit
Breaks and Polygala do not settle tolerance. Community notes describe 8→20 mg escalation over weeks and Polygala as a proposed workaround. A long-term commenter lost benefit after about 18 months despite intermittent use; Polygala and later four-to-five-month breaks did not restore it. Receptor downregulation remains an explanation people propose. Community Community Reddit
Stacks complicate the focus story. Caffeine with theanine, phenylpiracetam, Semax and Dihexa appear in community discussions; pairing use with learning sessions also appears. These accounts cannot identify each ingredient's contribution or prove stack synergy. Community
Capsules and dry powder need no peptide preparation. Community handling talk describes capped, dry, dark storage and moisture concerns. These are product-handling notes, not stability testing; there is no peptide reconstitution involved. Community

What the animal research contributes

A mouse response is supporting context. The 2013 Huntington-model study reports motor and survival benefits, using 1 mg/kg/day 4DMA versus 5 mg/kg/day parent 7,8-DHF. Brain signaling measured four hours after dosing is neither a human onset nor an elimination half-life. Animal context